Byetta vs Victoza
Drug comparison
Last updated 2026-05-28 15:46 UTCByetta (exenatide by AstraZeneca) and Victoza (liraglutide by Novo Nordisk) are both injectable medications for type 2 diabetes, but Victoza is also approved to reduce cardiovascular risk. Both are taken as daily shots under the skin, though Victoza’s dose may be adjusted over time. The key difference is their active ingredients: Byetta uses exenatide, while Victoza uses liraglutide.
AI summary of the sources below.
| Byetta | Victoza | |
|---|---|---|
| Active ingredient | exenatide | liraglutide |
| Manufacturer | astrazeneca | novo-nordisk |
| Route | subcutaneous injection | subcutaneous injection |
| FDA-approved for | type 2 diabetes | type 2 diabetes, cardiovascular risk reduction |
| Label updated | 2025-09-02 | 2023-02-06 |